Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Low E-Health Record Adoption Presents Challenge For R&D Use, AstraZeneca Informatics Scientist Says

Executive Summary

Adoption of EHRs “is not where it should be” to make them a valuable part of the drug R&D process, but progress is being made, according to AstraZeneca informatics scientist Sergio Eslava.

You may also be interested in...



ASCO Linking E-Health Data To Promote Real-Time Personalized Cancer Care

The American Society of Clinical Oncology takes the first big step toward a real-time learning network by aggregating data culled from electronic health records, to provide physicians, patients and others with up-to-the-minute evidence on how best to treat cancer.

HHS Seeks Suggestions On Hastening E-Health Record Interoperability, Data Exchange

Hinting that the electronic health record incentive program is not resulting in quick-enough adoption of interoperable systems, HHS asks for suggestions on how to speed up the process of making EHRs interoperable, as well as to get providers to utilize health information exchange.

Cancer Research Group Calls For EHR Link To Clinical Trial Databases

The American Association for Cancer Research recommends that meaningful use criteria include a requirement that electronic health records connect to clinical trial databases to encourage greater participation.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS142970

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel